Skip to main content
Clinical Trials/NCT01299441
NCT01299441
Terminated
Not Applicable

Noninvasive ECOM Monitoring of Hemodynamic Parameters During Liver Transplantation

Mayo Clinic1 site in 1 country40 target enrollmentFebruary 2011

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Liver Transplantation
Sponsor
Mayo Clinic
Enrollment
40
Locations
1
Primary Endpoint
endotracheal cardiac output monitor (ECOM), a non-invasive cardiac output monitor, is accurate and predictive
Status
Terminated
Last Updated
9 years ago

Overview

Brief Summary

The purpose of this study is to determine whether the endotracheal cardiac output monitor (ECOM) is accurate and predictive in liver failure patients with hyperdynamic circulatory changes.

Registry
clinicaltrials.gov
Start Date
February 2011
End Date
October 2016
Last Updated
9 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Timothy S. Shine, M.D.

PI

Mayo Clinic

Eligibility Criteria

Inclusion Criteria

  • Patients undergoing liver transplantation surgery

Exclusion Criteria

  • Patients who are anticipated to remain intubated postoperatively for greater than 24 hours.

Outcomes

Primary Outcomes

endotracheal cardiac output monitor (ECOM), a non-invasive cardiac output monitor, is accurate and predictive

Time Frame: Less than 24 hours

Pulmonary artery catheters are a standard of care for intraoperative hemodynamic assessment during liver transplantation. We propose to compare hemodynamic parameters obtained from PA catheters and ECOM. Use the endotracheal cardiac output monitor (ECOM) to evaluate multiple hemodynamic parameters (invasive blood pressure from the indwelling arterial catheter, noninvasive cardiac output via ECOM), and compare these to the parameters obtained from PA catheter.

Study Sites (1)

Loading locations...

Similar Trials